实体癌中靶向癌相关成纤维细胞的抗体药物偶联物（ADCs）
CAF-Targeting Antibody-Drug Conjugates (ADCs) in Solid Cancers.
作者信息
Papavassiliou Kostas A, Sofianidi Amalia A, Papavassiliou Athanasios G
机构信息
First University Department of Respiratory Medicine, 'Sotiria' Chest Hospital, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece.
Department of Biological Chemistry, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece.
出版信息
Cancers (Basel). 2025 May 14;17(10):1654. doi: 10.3390/cancers17101654.
Abstract
The tumor microenvironment (TME) constitutes a major part of solid malignancies and within it, cancer-associated fibroblasts (CAFs) continuously interact with cancer cells, fostering their growth and survival [...].
摘要
肿瘤微环境（TME）是实体恶性肿瘤的主要组成部分，在肿瘤微环境中，癌症相关成纤维细胞（CAF）持续与癌细胞相互作用，促进癌细胞的生长和存活 [...]。
相似文献
1
CAF-Targeting Antibody-Drug Conjugates (ADCs) in Solid Cancers.实体癌中靶向癌相关成纤维细胞的抗体药物偶联物（ADCs）
Cancers (Basel). 2025 May 14;17(10):1654. doi: 10.3390/cancers17101654.
2
Cancer-Associated Fibroblasts in Conversation with Tumor Cells in Endometrial Cancers: A Partner in Crime.癌症相关成纤维细胞与子宫内膜癌肿瘤细胞的对话：共犯关系。
Int J Mol Sci. 2021 Aug 24;22(17):9121. doi: 10.3390/ijms22179121.
3
A CAF-Based Two-Cell Hybrid Co-Culture Model to Test Drug Resistance in Endometrial Cancers.一种基于癌相关成纤维细胞的双细胞混合共培养模型，用于检测子宫内膜癌的耐药性。
Biomedicines. 2023 Apr 29;11(5):1326. doi: 10.3390/biomedicines11051326.
4
Targeting FAK improves the tumor uptake of antibody-drug conjugates to strengthen the anti-cancer responses.靶向粘着斑激酶可提高抗体药物偶联物的肿瘤摄取，以增强抗癌反应。
iScience. 2024 Dec 6;28(3):111536. doi: 10.1016/j.isci.2024.111536. eCollection 2025 Mar 21.
5
Broadening Drug Design and Targets to Tumor Microenvironment? Cancer-Associated Fibroblast Marker Expression in Cancers and Relevance for Survival Outcomes.拓展针对肿瘤微环境的药物设计与靶点？癌症相关成纤维细胞标志物在癌症中的表达及其与生存结果的相关性
OMICS. 2020 Jun;24(6):340-351. doi: 10.1089/omi.2020.0042.
6
Bête Noire of Chemotherapy and Targeted Therapy: CAF-Mediated Resistance.化疗和靶向治疗的棘手问题：CAF介导的耐药性
Cancers (Basel). 2022 Mar 16;14(6):1519. doi: 10.3390/cancers14061519.
7
Cancer-associated fibroblasts in intrahepatic cholangiocarcinoma progression and therapeutic resistance.肝内胆管癌进展和治疗耐药中的癌症相关成纤维细胞
Adv Cancer Res. 2022;156:201-226. doi: 10.1016/bs.acr.2022.01.009. Epub 2022 Feb 24.
8
Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives.肿瘤微环境中癌症相关成纤维细胞与免疫细胞的串扰：新发现与未来展望。
Mol Cancer. 2021 Oct 11;20(1):131. doi: 10.1186/s12943-021-01428-1.
9
Mesothelioma-associated fibroblasts enhance proliferation and migration of pleural mesothelioma cells via c-Met/PI3K and WNT signaling but do not protect against cisplatin.间皮瘤相关成纤维细胞通过 c-Met/PI3K 和 WNT 信号增强胸膜间皮瘤细胞的增殖和迁移，但不能对抗顺铂。
J Exp Clin Cancer Res. 2023 Jan 23;42(1):27. doi: 10.1186/s13046-022-02582-0.
10
Metabolic and Immunological Implications of MMECAF-Mediated Hypoxia Signaling in Pancreatic Cancer Progression: Therapeutic Insights and Translational Opportunities.MMECAF介导的缺氧信号在胰腺癌进展中的代谢和免疫影响：治疗见解与转化机遇
Biol Proced Online. 2024 Sep 28;26(1):29. doi: 10.1186/s12575-024-00254-1.
本文引用的文献
1
Targeting FAK improves the tumor uptake of antibody-drug conjugates to strengthen the anti-cancer responses.靶向粘着斑激酶可提高抗体药物偶联物的肿瘤摄取，以增强抗癌反应。
iScience. 2024 Dec 6;28(3):111536. doi: 10.1016/j.isci.2024.111536. eCollection 2025 Mar 21.
2
FGFR‑related phenotypic and functional profile of CAFs in prognostication of breast cancer (Review).成纤维细胞生长因子受体相关表型和功能特征在乳腺癌预后中的作用（综述）。
Int J Oncol. 2024 Oct;65(4). doi: 10.3892/ijo.2024.5682. Epub 2024 Sep 2.
3
Mechanistic Characterization of Cancer-associated Fibroblast Depletion via an Antibody-Drug Conjugate Targeting Fibroblast Activation Protein.通过靶向成纤维细胞活化蛋白的抗体药物偶联物对癌症相关成纤维细胞耗竭的机制表征
Cancer Res Commun. 2024 Jun 12;4(6):1481-1494. doi: 10.1158/2767-9764.CRC-24-0248.
4
Cancer-associated fibroblast classification in single-cell and spatial proteomics data.单细胞和空间蛋白质组学数据中的癌症相关成纤维细胞分类。
Nat Commun. 2023 Jul 18;14(1):4294. doi: 10.1038/s41467-023-39762-1.
5
Integrated single-cell and bulk RNA sequencing analysis identifies a cancer-associated fibroblast-related gene signature for predicting survival and therapy in gastric cancer.单细胞和 bulk RNA 测序分析整合鉴定出一个与癌症相关的成纤维细胞相关基因特征，可用于预测胃癌患者的生存和治疗反应。
BMC Cancer. 2023 Jan 31;23(1):108. doi: 10.1186/s12885-022-10332-w.
6
The Cancer-Associated Fibroblasts-Related Gene COMP Is a Novel Predictor for Prognosis and Immunotherapy Efficacy and Is Correlated with M2 Macrophage Infiltration in Colon Cancer.癌症相关成纤维细胞相关基因 COMP 是一种新的预测结肠癌预后和免疫治疗疗效的标志物，与 M2 巨噬细胞浸润相关。
Biomolecules. 2022 Dec 28;13(1):62. doi: 10.3390/biom13010062.
7
uPARAP/Endo180: a multifaceted protein of mesenchymal cells.uPARAP/Endo180：间充质细胞的多功能蛋白。
Cell Mol Life Sci. 2022 Apr 22;79(5):255. doi: 10.1007/s00018-022-04249-7.
8
Fibroblast Activation Protein-α as a Target in the Bench-to-Bedside Diagnosis and Treatment of Tumors: A Narrative Review.成纤维细胞活化蛋白-α作为肿瘤从 bench 到 bedside 诊断与治疗的靶点：一篇叙述性综述
Front Oncol. 2021 Aug 19;11:648187. doi: 10.3389/fonc.2021.648187. eCollection 2021.
9
A phase 1 study of LY3076226, a fibroblast growth factor receptor 3 (FGFR3) antibody-drug conjugate, in patients with advanced or metastatic cancer.一项评估 LY3076226（一种成纤维细胞生长因子受体 3（FGFR3）抗体药物偶联物）在晚期或转移性癌症患者中的安全性、耐受性、药代动力学和初步疗效的 1 期研究。
Invest New Drugs. 2021 Dec;39(6):1613-1623. doi: 10.1007/s10637-021-01146-x. Epub 2021 Jul 15.
10
Impairment of a distinct cancer-associated fibroblast population limits tumour growth and metastasis.特定的癌相关成纤维细胞群体的损伤限制了肿瘤生长和转移。
Nat Commun. 2021 Jun 10;12(1):3516. doi: 10.1038/s41467-021-23583-1.
Zotero 插件